Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial.
Saved in:
| Title: | Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial. |
|---|---|
| Authors: | Gebhart, G.1 geraldine.gebhart@bordet.be, Lamberts, L. E.2, Wimana, Z.1, Garcia, C.1, Emonts, P.1, Ameye, L.1, Stroobants, S.3, Huizing, M.3, Aftimos, P.1, Tol, J.4, Oyen, W. J. G.4, Vugts, D. J.5, Hoekstra, O. S.5, Schröder, C. P.2, der Houven van Oordt, C. W. Menke-van5, Guiot, T.1, Brouwers, A. H.2, Awada, A.1, de Vries, E. G. E.2, Flamen, P.1 |
| Source: | Annals of Oncology. Apr2016, Vol. 27 Issue 4, p619-624. 6p. 1 Diagram, 1 Graph. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 114039667 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Gebhart%2C+G%2E%22">Gebhart, G.</searchLink><relatesTo>1</relatesTo><i> geraldine.gebhart@bordet.be</i><br /><searchLink fieldCode="AR" term="%22Lamberts%2C+L%2E+E%2E%22">Lamberts, L. E.</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Wimana%2C+Z%2E%22">Wimana, Z.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Garcia%2C+C%2E%22">Garcia, C.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Emonts%2C+P%2E%22">Emonts, P.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Ameye%2C+L%2E%22">Ameye, L.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Stroobants%2C+S%2E%22">Stroobants, S.</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Huizing%2C+M%2E%22">Huizing, M.</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Aftimos%2C+P%2E%22">Aftimos, P.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Tol%2C+J%2E%22">Tol, J.</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22Oyen%2C+W%2E+J%2E+G%2E%22">Oyen, W. J. G.</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22Vugts%2C+D%2E+J%2E%22">Vugts, D. J.</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Hoekstra%2C+O%2E+S%2E%22">Hoekstra, O. S.</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Schröder%2C+C%2E+P%2E%22">Schröder, C. P.</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22der+Houven+van+Oordt%2C+C%2E+W%2E+Menke-van%22">der Houven van Oordt, C. W. Menke-van</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Guiot%2C+T%2E%22">Guiot, T.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Brouwers%2C+A%2E+H%2E%22">Brouwers, A. H.</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Awada%2C+A%2E%22">Awada, A.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22de+Vries%2C+E%2E+G%2E+E%2E%22">de Vries, E. G. E.</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Flamen%2C+P%2E%22">Flamen, P.</searchLink><relatesTo>1</relatesTo> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. Apr2016, Vol. 27 Issue 4, p619-624. 6p. 1 Diagram, 1 Graph. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=114039667 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/annonc/mdv577 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 6 StartPage: 619 Titles: – TitleFull: Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Gebhart, G. – PersonEntity: Name: NameFull: Lamberts, L. E. – PersonEntity: Name: NameFull: Wimana, Z. – PersonEntity: Name: NameFull: Garcia, C. – PersonEntity: Name: NameFull: Emonts, P. – PersonEntity: Name: NameFull: Ameye, L. – PersonEntity: Name: NameFull: Stroobants, S. – PersonEntity: Name: NameFull: Huizing, M. – PersonEntity: Name: NameFull: Aftimos, P. – PersonEntity: Name: NameFull: Tol, J. – PersonEntity: Name: NameFull: Oyen, W. J. G. – PersonEntity: Name: NameFull: Vugts, D. J. – PersonEntity: Name: NameFull: Hoekstra, O. S. – PersonEntity: Name: NameFull: Schröder, C. P. – PersonEntity: Name: NameFull: der Houven van Oordt, C. W. Menke-van – PersonEntity: Name: NameFull: Guiot, T. – PersonEntity: Name: NameFull: Brouwers, A. H. – PersonEntity: Name: NameFull: Awada, A. – PersonEntity: Name: NameFull: de Vries, E. G. E. – PersonEntity: Name: NameFull: Flamen, P. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: Apr2016 Type: published Y: 2016 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 27 – Type: issue Value: 4 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |
